Trump’s Second Administration: Impact on the Pharmaceutical Industry

The second Trump administration has been in office for just over one year, but the whirlwind of activity across all areas of the government has created a constant stream of discussion and implementation of policy changes.

Meanwhile, the pharmaceutical industry has maintained strong growth over the past few years, fueled by technological innovation, an aging population, and strategic investments. Our prior blog series “Cancer Drugs: Antibody Drug Conjugates (ADCs) Keep Growing” highlighted some of these technological innovations and analyzed legal issues associated with these advancements. Our “AI in Health Care Series” discussed advances in AI and biotech, as well as legal questions that surround these remarkable developments.

In this new series, we will focus on recent developments under the current Trump administration and their impact on the pharmaceutical industry. These topics include:

Increased oversight from State Attorney General’s Offices as many of the federal agencies reduce their headcount.
Data privacy concerns relevant to the pharmaceutical industry.
Pricing pressures in the life sciences and pharmaceutical industry.
Branding issues unique to companies selling and marketing pharmaceuticals.

In addition, we will continue to provide updates on corporate, regulatory, and intellectual property legal issues of interest to the industry.

For additional resources on the Trump Administration’s impact on the pharmaceutical industry, visit Foley’s Trump Administration Resource Hub.

Foley is here to help you address the short- and long-term impacts in the wake of regulatory changes. We have the resources to help you navigate these and other important legal considerations related to business operations and industry-specific issues. Please reach out to the authors, your Foley relationship partner, our Health Care & Life Sciences Sector, or to our Innovative Technology Sector with any questions.

Disclaimer

This blog is made available by ��; Lardner LLP (“Foley” or “the Firm”) for informational purposes only. It is not meant to convey the Firm’s legal position on behalf of any client, nor is it intended to convey specific legal advice. Any opinions expressed in this article do not necessarily reflect the views of ��; Lardner LLP, its partners, or its clients. Accordingly, do not act upon this information without seeking counsel from a licensed attorney. This blog is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Communicating with Foley through this website by email, blog post, or otherwise, does not create an attorney-client relationship for any legal matter. Therefore, any communication or material you transmit to Foley through this blog, whether by email, blog post or any other manner, will not be treated as confidential or proprietary. The information on this blog is published “AS IS” and is not guaranteed to be complete, accurate, and or up-to-date. Foley makes no representations or warranties of any kind, express or implied, as to the operation or content of the site. Foley expressly disclaims all other guarantees, warranties, conditions and representations of any kind, either express or implied, whether arising under any statute, law, commercial use or otherwise, including implied warranties of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Foley or any of its partners, officers, employees, agents or affiliates be liable, directly or indirectly, under any theory of law (contract, tort, negligence or otherwise), to you or anyone else, for any claims, losses or damages, direct, indirect special, incidental, punitive or consequential, resulting from or occasioned by the creation, use of or reliance on this site (including information and other content) or any third party websites or the information, resources or material accessed through any such websites. In some jurisdictions, the contents of this blog may be considered Attorney Advertising. If applicable, please note that prior results do not guarantee a similar outcome. Photographs are for dramatization purposes only and may include models. Likenesses do not necessarily imply current client, partnership or employee status.